News from Jiangsu
Stay current with all the latest and breaking news about Jiangsu, compare headlines and perspectives between news sources on stories happening today. In total, 284 stories have been published about Jiangsu which Ground News has aggregated in the past 3 months.
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Jiangsu News
Latest News Stories
Jiangsu · JiangsuThe reactor vessel and two steam generators, with a combined weight of more than 1000 tonnes, will travel by road, river and sea from Russia to the Tianwan site in China's Jiangsu province.See the Story
Reactor vessel and steam generators shipped for Tianwan 8 : New Nuclear - World Nuclear News
Lianyungang · LianyungangIn Lianyungang, Jiangsu, a boy who was once treated as a negative textbook for “hitting the wheel” was given a car to his father 4 years later. The related topic hit the headlines. Li Xiao, a post-00s boy, is known as “Wang Zhe Rongyao, the Great God of National Service.” He revealed that he became a “game trainer” after graduation. No one around him was optimistic at the time, and even treated him as a “negative textbook”. Only his father suppo…See the Story
A junior high school degree as a game agent only supports a 19-year-old child 4 years later and is envied by the whole network
Nanjing · NanjingZhou Yinting, who debuted for 9 years, was the head of the first concert “WHO IS YAN TING LIVE 2024” at the Jiuzhan Festival last night. After appearing in a snakeskin suit and showing her chest muscles, Zhou Yin-ting sang songs such as “Killa” and “Hello Miss,” and as an MV director, he later sang MV songs from his past mentor. Afterwards, he said that tonight's concert was self-directed and performed by himself, and there were many stories, mu…See the Story
YAN Ting Concert丨Self-written, Self-directed, and Self-directed, Big Show Skin Group Boy Band, Tyson, the Golden Sentence Challenge Machine, Gin Lin shouts, is unforgettable and dying to help
Xuzhou · XuzhouA photo showing what appears to be a United States-built Patriot air defense system somewhere in China has begun to make its rounds across the internet today, causing a whirlwind of speculation about its origin. Simply put, it’s an inert mock-up meant for training purposes, also known as a VISMOD. The Photo and Online Claims The photo shows what looks like a Patriot system being towed on a flatbed truck. The mandarin on part of the bed shows the…See the Story
Chinese Patriot SAM Mock-Up Causes Buzz Online
Nanjing · NanjingGhost Bots In China, the AI cloning of dead relatives has become a thriving cottage industry, driving down prices and spurring technological advances in the years since these kinds of services have been offered. In an interview with NPR, MIT Tech Review reporter Zeyi Yang discussed the fascinating, if not macabre, industry he covered for a piece at his employer. According to his reporting, mourners can now purchase AI replicas of their deceased …See the Story
People Are Selling AI Clones of Dead Relatives for Just $150
100% Left coverage: 1 sources
Nanjing · NanjingA young associate professor who taught at Nanjing Forestry University recently died by suicide. According to online news, the young scholar was originally a “talent” introduced by Nanlin University, but he did not pass the exam last year. He was demoted to a lecturer by the school, and he also requested a refund of part of the “home settlement expenses” that had already been paid. Netizens questioned the school's “go without promotion” policy, c…See the Story
A young scientist at Nanjing Forestry University committed suicide after being demoted after failing the first term of employment, the “don't get promoted and go” policy draws attention
Jiangsu · Jiangsu— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED's surufatinib and anti-PD-1 activity with Hengrui's camrelizumab, promoting the immune response against tumor cells — HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:…See the Story
HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui - HUTCHMED (China) (NASDAQ:HCM)
100% Center coverage: 1 sources